Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate”

Detalles Bibliográficos
Autores principales: Cahn, Rachel Tallman, Zinn, Zachary, Kolodney, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912810/
https://www.ncbi.nlm.nih.gov/pubmed/36773822
http://dx.doi.org/10.1016/j.jaad.2023.02.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912810/
https://www.ncbi.nlm.nih.gov/pubmed/36773822
http://dx.doi.org/10.1016/j.jaad.2023.02.002

Ejemplares similares